| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.ATV.0000177807.54959.7D |
| P698 | PubMed publication ID | 16020751 |
| P50 | author | Alberto Mantovani | Q22069468 |
| Barbara Bottazzi | Q42306567 | ||
| Marco Rusnati | Q56811108 | ||
| Marco Presta | Q56855374 | ||
| Serena Zacchigna | Q57074112 | ||
| Mauro Giacca | Q57074140 | ||
| Daniela Coltrini | Q89581711 | ||
| Maura Camozzi | Q117275016 | ||
| P2093 | author name string | Genaro Ramirez-Correa | |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1837-1842 | |
| P577 | publication date | 2005-07-14 | |
| P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
| P1476 | title | Pentraxin 3 inhibits fibroblast growth factor 2-dependent activation of smooth muscle cells in vitro and neointima formation in vivo | |
| P478 | volume | 25 |
| Q37729085 | Apolipoprotein A-I inhibits LPS-induced atherosclerosis in ApoE(-/-) mice possibly via activated STAT3-mediated upregulation of tristetraprolin |
| Q34150807 | Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study |
| Q47941184 | Atorvastatin reduces long pentraxin 3 expression in vascular cells by inhibiting protein geranylgeranylation |
| Q51802963 | Circulating pentraxin 3 levels are higher in metabolic syndrome with subclinical atherosclerosis: evidence for association with atherogenic lipid profile. |
| Q46071688 | Determination of physiological plasma pentraxin 3 (PTX3) levels in healthy populations |
| Q24324037 | Direct and heterologous approaches to identify the LET-756/FGF interactome |
| Q37318049 | Extracellular interactome of the FGF receptor-ligand system: complexities and the relative simplicity of the worm |
| Q37294970 | Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived anti-angiogenic pentapeptide |
| Q36463833 | Host-protective effect of circulating pentraxin 3 (PTX3) and complex formation with neutrophil extracellular traps. |
| Q51585406 | Identification of an antiangiogenic FGF2-binding site in the N terminus of the soluble pattern recognition receptor PTX3. |
| Q36426931 | Implication of the oligomeric state of the N-terminal PTX3 domain in cumulus matrix assembly |
| Q34377832 | Intravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum. |
| Q57817458 | Long Pentraxin-3 Modulates the Angiogenic Activity of Fibroblast Growth Factor-2 |
| Q37944361 | Long pentraxin 3 (PTX3) in the light of its structure, mechanism of action and clinical implications |
| Q28118263 | Long pentraxin 3/tumor necrosis factor-stimulated gene-6 interaction: a biological rheostat for fibroblast growth factor 2-mediated angiogenesis |
| Q36830914 | Long pentraxin 3: experimental and clinical relevance in cardiovascular diseases |
| Q36538797 | Low circulating pentraxin 3 levels in pregnancy is associated with gestational diabetes and increased apoB/apoA ratio: a 5-year follow-up study |
| Q35054493 | Pathogen recognition by the long pentraxin PTX3. |
| Q31057428 | Pentraxin 3 (PTX3) expression in allergic asthmatic airways: role in airway smooth muscle migration and chemokine production |
| Q64105040 | Pentraxin 3 in Cardiovascular Disease |
| Q36889123 | Pentraxin 3: an immuno-regulator in the lungs |
| Q34683473 | Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3. |
| Q35140370 | Plasma pentraxin 3 levels do not predict coronary events but reflect metabolic disorders in patients with coronary artery disease in the CARE trial |
| Q35309510 | Protective molecules and their cognate antibodies: new players in autoimmunity |
| Q36924394 | Role of the soluble pattern recognition receptor PTX3 in vascular biology |
| Q56942323 | Selective up-regulation of the soluble pattern-recognition receptor pentraxin 3 and of vascular endothelial growth factor in giant cell arteritis: Relevance for recent optic nerve ischemia |
| Q46788898 | Structural characterization of PTX3 disulfide bond network and its multimeric status in cumulus matrix organization |
| Q34579101 | Systemic pentraxin-3 levels reflect vascular enhancement and progression in Takayasu arteritis |
| Q33632047 | The Dual Complexity of PTX3 in Health and Disease: A Balancing Act? |
| Q64076093 | The Long Pentraxin PTX3 as a Link Between Innate Immunity, Tissue Remodeling, and Cancer |
| Q28118397 | The angiogenic inhibitor long pentraxin PTX3 forms an asymmetric octamer with two binding sites for FGF2 |
| Q26738957 | The inflammatory protein Pentraxin 3 in cardiovascular disease |
| Q37851153 | The long pentraxin PTX3 at the crossroads between innate immunity and tissue remodelling |
| Q48193738 | The long pentraxin PTX3: A prototypical sensor of tissue injury and a regulator of homeostasis |
| Q38092832 | The long pentraxin PTX3: a paradigm for humoral pattern recognition molecules |
| Q47626900 | Update on the role of Pentraxin 3 in atherosclerosis and cardiovascular diseases |
| Q36869842 | Vascular pentraxin 3 controls arterial thrombosis by targeting collagen and fibrinogen induced platelets aggregation |
Search more.